Allstate Corporation’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.7M Buy
595,780
+177,142
+42% +$4.72M 0.18% 75
2025
Q4
$10.4M Buy
418,638
+214,443
+105% +$5.41M 0.14% 99
2025
Q3
$5.2M Buy
204,195
+195,335
+2,205% +$4.82M 0.12% 95
2025
Q2
$215K Sell
8,860
-213,403
-96% -$4.98M 0.02% 166
2025
Q1
$5.63M Buy
222,263
+54,287
+32% +$1.42M 0.17% 75
2024
Q4
$4.46M Buy
+167,976
New +$4.56M 0.13% 84
2024
Q3
Sell
-15,872
Closed -$444K 198
2024
Q2
$444K Buy
15,872
+1,862
+13% +$51.3K 0.04% 129
2024
Q1
$389K Sell
14,010
-6,033
-30% -$167K 0.03% 139
2023
Q4
$577K Buy
20,043
+588
+3% +$17.8K 0.04% 95
2023
Q3
$645K Hold
19,455
0.04% 92
2023
Q2
$714K Sell
19,455
-138
-0.7% -$5.37K 0.05% 90
2023
Q1
$799K Sell
19,593
-209,176
-91% -$9.03M 0.06% 78
2022
Q4
$11.7M Buy
228,769
+3,132
+1% +$150K 0.36% 41
2022
Q3
$9.87M Sell
225,637
-1,064
-0.5% -$51.7K 0.28% 49
2022
Q2
$11.9M Sell
226,701
-204,265
-47% -$10.4M 0.37% 40
2022
Q1
$22.3M Buy
430,966
+23,533
+6% +$1.22M 0.6% 26
2021
Q4
$24.1M Buy
407,433
+299,828
+279% +$14.9M 0.46% 33
2021
Q3
$4.63M Sell
107,605
-7,822
-7% -$347K 0.19% 44
2021
Q2
$4.52M Sell
115,427
-16,133
-12% -$627K 0.15% 53
2021
Q1
$4.77M Sell
131,560
-1,149
-0.9% -$40.8K 0.15% 55
2020
Q4
$4.88M Sell
132,709
-78
-0.1% -$2.86K 0.15% 48
2020
Q3
$4.62M Sell
132,787
-22,537
-15% -$790K 0.15% 45
2020
Q2
$4.82M Sell
155,324
-12,236
-7% -$416K 0.17% 49
2020
Q1
$5.19M Sell
167,560
-243,925
-59% -$8.31M 0.2% 40
2019
Q4
$15.3M Sell
411,485
-712
-0.2% -$25.4K 0.28% 37
2019
Q3
$14.1M Sell
412,197
-166,221
-29% -$6.04M 0.24% 42
2019
Q2
$23.8M Buy
578,418
+99,561
+21% +$3.95M 0.42% 27
2019
Q1
$19.3M Sell
478,857
-2,750
-0.6% -$110K 0.52% 26
2018
Q4
$19.9M Buy
481,607
+473,837
+6,098% +$19.7M 0.66% 21
2018
Q3
$325K Sell
7,770
-293
-4% -$11.3K 0.02% 25
2018
Q2
$278K Buy
8,063
+1,960
+32% +$67K 0.01% 26
2018
Q1
$205K Buy
6,103
+47
+0.8% +$1.62K 0.01% 25
2017
Q4
$208K Buy
+6,056
New +$206K 0.01% 25
2017
Q3
Sell
-172,848
Closed -$5.51M 194
2017
Q2
$5.51M Sell
172,848
-17,342
-9% -$547K 0.29% 20
2017
Q1
$6.17M Sell
190,190
-148,702
-44% -$4.69M 0.37% 27
2016
Q4
$10.4M Buy
338,892
+12,636
+4% +$386K 0.62% 39
2016
Q3
$10.5M Sell
326,256
-57,479
-15% -$1.92M 0.74% 18
2016
Q2
$12.8M Buy
383,735
+99,765
+35% +$3.18M 0.84% 19
2016
Q1
$7.99M Sell
283,970
-168,580
-37% -$4.82M 0.69% 45
2015
Q4
$13.9M Buy
452,550
+328,765
+266% +$10.3M 1.32% 16
2015
Q3
$3.69M Sell
123,785
-2,688
-2% -$86.2K 0.38% 62
2015
Q2
$4.02M Sell
126,473
-457,379
-78% -$14.9M 0.36% 70
2015
Q1
$19.3M Buy
583,852
+17,850
+3% +$567K 1.61% 7
2014
Q4
$16.7M Buy
566,002
+413,091
+270% +$11.8M 1.28% 12
2014
Q3
$4.29M Buy
+152,911
New +$4.29M 0.2% 173

Other funds holding PFE

Allstate Corporation's PFE Position: Q1 2026 in Review

Allstate Corporation increased its Pfizer (PFE) stake by 42% in Q1 2026, buying an estimated $4.72M and bringing the position to 595,780 shares worth $16.7M. The position accounts for 0.18% of the portfolio, ranked #75.

Allstate Corporation first reported a position in PFE in Q3 2014 and has held it in 45 quarters since. The position peaked at $24.1M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Allstate Corporation held 595,780 shares of Pfizer worth $16.7M as of Q1 2026.
  • Allstate Corporation bought 177,142 Pfizer shares in Q1 2026, an estimated $4.72M.
  • Pfizer made up 0.18% of Allstate Corporation's portfolio in Q1 2026, its #75 holding.
  • Allstate Corporation first reported a position in Pfizer in Q3 2014 and has held it in 45 quarters since.
  • Allstate Corporation's Pfizer position peaked at $24.1M in Q4 2021.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.